Literature DB >> 27538267

Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.

O Jalil1, A Afaq2, B Ganeshan2, U B Patel3, D Boone1, R Endozo2, A Groves2, B Sizer1, T Arulampalam1.   

Abstract

AIM: The study aimed to investigate whether textural features of rectal cancer on MRI can predict long-term survival in patients treated with long-course chemoradiotherapy.
METHOD: Textural analysis (TA) using a filtration-histogram technique of T2-weighted pre- and 6-week post-chemoradiotherapy MRI was undertaken using TexRAD, a proprietary software algorithm. Regions of interest enclosing the largest cross-sectional area of the tumour were manually delineated on the axial images and the filtration step extracted features at different anatomical scales (fine, medium and coarse) followed by quantification of statistical features [mean intensity, standard deviation, entropy, skewness, kurtosis and mean of positive pixels (MPP)] using histogram analysis. Cox multiple regression analysis determined which univariate features including textural, radiological and histological independently predicted overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS).
RESULTS: MPP [fine texture, hazard ratio (HR) 6.9, 95% CI: 2.43-19.55, P < 0.001], mean (medium texture, HR 5.6, 95% CI: 1.4-21.7, P = 0.007) and extramural venous invasion (EMVI) on MRI (HR 2.96, 95% CI: 1.04-8.37, P = 0.041) independently predicted OS while mean (medium texture, HR 4.53, 95% CI: 1.58-12.94, P = 0.003), MPP (fine texture, HR 3.36, 95% CI: 1.36-8.31, P = 0.008) and threatened circumferential resection margin (CRM) on MRI (HR 3.1, 95% CI: 1.01-9.46, P = 0.046) predicted DFS. For OS, EMVI on MRI (HR 4.23, 95% CI: 1.41-12.69, P = 0.01) and for DFS kurtosis (medium texture, HR 3.97, 95% CI: 1.44-10.94, P = 0.007) and CRM involvement on MRI (HR 3.36, 95% CI: 1.21-9.32, P = 0.02) were the independent post-treatment factors. Only TA independently predicted RFS on pre- or post-treatment analyses.
CONCLUSION: MR based TA of rectal cancers can predict outcome before undergoing surgery and could potentially select patients for individualized therapy. Colorectal Disease
© 2016 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  MRI; Textural analysis; imaging biomarker; neoadjuvant chemoradiotherapy; rectal cancer

Mesh:

Substances:

Year:  2017        PMID: 27538267     DOI: 10.1111/codi.13496

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  19 in total

1.  Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features.

Authors:  V Giannini; S Mazzetti; I Bertotto; C Chiarenza; S Cauda; E Delmastro; C Bracco; A Di Dia; F Leone; E Medico; A Pisacane; D Ribero; M Stasi; D Regge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-13       Impact factor: 9.236

2.  Can MR textural analysis improve the prediction of extracapsular nodal spread in patients with oral cavity cancer?

Authors:  Russell Frood; Ebrahim Palkhi; Mark Barnfield; Robin Prestwich; Sriram Vaidyanathan; Andrew Scarsbrook
Journal:  Eur Radiol       Date:  2018-06-05       Impact factor: 5.315

3.  Rectal cancer: can T2WI histogram of the primary tumor help predict the existence of lymph node metastasis?

Authors:  Lanqing Yang; Dan Liu; Xin Fang; Ziqiang Wang; Yue Xing; Ling Ma; Bing Wu
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

4.  Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I-III colorectal cancer.

Authors:  Yanqi Huang; Lan He; Zhenhui Li; Xin Chen; Chu Han; Ke Zhao; Yuan Zhang; Jinrong Qu; Yun Mao; Changhong Liang; Zaiyi Liu
Journal:  Chin J Cancer Res       Date:  2022-02-28       Impact factor: 5.087

Review 5.  Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.

Authors:  Natally Horvat; David D B Bates; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2019-11

6.  Preoperative volumetric synthetic magnetic resonance imaging of the primary tumor for a more accurate prediction of lymph node metastasis in rectal cancer.

Authors:  Li Zhao; Meng Liang; Zhuo Shi; Lizhi Xie; Hongmei Zhang; Xinming Zhao
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 7.  Novelties in treatment of locally advanced rectal cancer.

Authors:  Fabian Grass; Kellie Mathis
Journal:  F1000Res       Date:  2018-11-29

8.  Characterizing MRI features of rectal cancers with different KRAS status.

Authors:  Yanyan Xu; Qiaoyu Xu; Yanhui Ma; Jianghui Duan; Haibo Zhang; Tongxi Liu; Lu Li; Hongliang Sun; Kaining Shi; Sheng Xie; Wu Wang
Journal:  BMC Cancer       Date:  2019-11-14       Impact factor: 4.430

9.  Adaptive statistical iterative reconstruction (ASIR) affects CT radiomics quantification in primary colorectal cancer.

Authors:  Davide Prezzi; Katarzyna Owczarczyk; Paul Bassett; Muhammad Siddique; David J Breen; Gary J R Cook; Vicky Goh
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

Review 10.  Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives.

Authors:  Gianluca Pellino; Gaetano Gallo; Pierlorenzo Pallante; Raffaella Capasso; Alfonso De Stefano; Isacco Maretto; Umberto Malapelle; Shengyang Qiu; Stella Nikolaou; Andrea Barina; Giuseppe Clerico; Alfonso Reginelli; Antonio Giuliani; Guido Sciaudone; Christos Kontovounisios; Luca Brunese; Mario Trompetto; Francesco Selvaggi
Journal:  Gastroenterol Res Pract       Date:  2018-06-13       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.